Abstract
(Abstracted from N Engl J Med 2020;383:2514–2525) The use of antenatal glucocorticoids to reduce infant morbidity and mortality associated with preterm birth has been supported by a number of studies conducted in high-resource countries. However, a 2015 population-based trial conducted in low-resource countries called their use into question.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
